45
Active Moiety Name FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is included in the Highlights Indications and Usage heading if a drug is a member of an EPC [see 21 CFR 201.57(a)(6)]: “(Drug) is a (FDA EPC Text Phrase) indicated for [indication(s)].” For each listed active moiety, the associated FDA EPC text phrase is included in this document. For more information about how FDA determines the EPC Text Phrase, see the 2009 "Determining EPC for Use in the Highlights" guidance and 2013 "Determining EPC for Use in the Highlights" MAPP 7400.13. finasteride 5-alpha reductase inhibitor dutasteride 5-alpha reductase inhibitor zileuton 5-lipoxygenase inhibitor botulinum toxin type a acetylcholine release inhibitor rimabotulinumtoxinb acetylcholine release inhibitor guanidine acetylcholine releasing agent dactinomycin actinomycin regadenoson anhydrous adenosine receptor agonist adenosine adenosine receptor agonist regadenoson adenosine receptor agonist aminoglutethimide adrenal steroid synthesis inhibitor metyrapone adrenal steroid synthesis inhibitor hydroxyamphetamine adrenergic agonist dipivefrin adrenergic agonist epinastine adrenergic agonist epinastine adrenergic agonist cosyntropin adrenocorticotropic hormone corticotropin adrenocorticotropic hormone disulfiram aldehyde dehydrogenase inhibitor eplerenone aldosterone antagonist spironolactone aldosterone antagonist chlorambucil alkylating drug cyclophosphamide alkylating drug cyclophosphamide anhydrous alkylating drug mechlorethamine alkylating drug trabectedin alkylating drug altretamine alkylating drug bendamustine alkylating drug busulfan alkylating drug carmustine alkylating drug dacarbazine alkylating drug

FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

Embed Size (px)

Citation preview

Page 1: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

Active Moiety Name

FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is included in the Highlights Indications and Usage heading if a drug is a member of an EPC [see 21 CFR 201.57(a)(6)]: “(Drug) is a (FDA EPC Text Phrase) indicated for [indication(s)].” For each listed active moiety, the associated FDA EPC text phrase is included in this document. For more information about how FDA determines the EPC Text Phrase, see the 2009 "Determining EPC for Use in the Highlights" guidance and 2013 "Determining EPC for Use in the Highlights" MAPP 7400.13.

finasteride 5-alpha reductase inhibitordutasteride 5-alpha reductase inhibitorzileuton 5-lipoxygenase inhibitorbotulinum toxin type a acetylcholine release inhibitorrimabotulinumtoxinb acetylcholine release inhibitorguanidine acetylcholine releasing agentdactinomycin actinomycinregadenoson anhydrous adenosine receptor agonistadenosine adenosine receptor agonistregadenoson adenosine receptor agonistaminoglutethimide adrenal steroid synthesis inhibitormetyrapone adrenal steroid synthesis inhibitorhydroxyamphetamine adrenergic agonistdipivefrin adrenergic agonistepinastine adrenergic agonistepinastine adrenergic agonistcosyntropin adrenocorticotropic hormonecorticotropin adrenocorticotropic hormonedisulfiram aldehyde dehydrogenase inhibitoreplerenone aldosterone antagonistspironolactone aldosterone antagonistchlorambucil alkylating drugcyclophosphamide alkylating drugcyclophosphamide anhydrous alkylating drugmechlorethamine alkylating drugtrabectedin alkylating drugaltretamine alkylating drugbendamustine alkylating drugbusulfan alkylating drugcarmustine alkylating drugdacarbazine alkylating drug

Page 2: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

estramustine alkylating drugifosfamide alkylating druglomustine alkylating drugmelphalan alkylating drugmitomycin alkylating drugprocarbazine alkylating drugstreptozocin alkylating drugtemozolomide alkylating drugthiotepa alkylating drughuman cord blood hematopoietic progenitor cell

allogeneic cord blood hematopoietic progenitor cell therapy

bovine type i collagen allogeneic cultured cell scaffoldforeskin fibroblast (neonatal) allogeneic cultured cell scaffold

foreskin keratinocyte (neonatal) allogeneic cultured cell scaffold

naftifine allylamine antifungalterbinafine allylamine antifungalephedrine alpha adrenergic agonistepinephrine alpha adrenergic agonistapraclonidine alpha adrenergic agonistbrimonidine alpha adrenergic agonistmidodrine alpha adrenergic agonistpseudoephedrine alpha adrenergic agonistdapiprazole alpha adrenergic blockeralfuzosin alpha adrenergic blockercarvedilol alpha adrenergic blockerdoxazosin alpha adrenergic blockerphenoxybenzamine alpha adrenergic blockerphentolamine alpha adrenergic blockerprazosin alpha adrenergic blockersilodosin alpha adrenergic blockertamsulosin alpha adrenergic blockerterazosin alpha adrenergic blockeracarbose alpha glucosidase inhibitormiglitol alpha glucosidase inhibitorammonium lactate alpha hydroxy acidradium ra-223 cation alpha particle-emitting radioactive therapeutic agentphenylephrine alpha-1 adrenergic receptor agonistsucralfate aluminum complexbupivacaine amide local anestheticlidocaine amide local anestheticarticaine amide local anestheticmepivacaine amide local anestheticprilocaine amide local anestheticropivacaine amide local anestheticalanine amino acidglutamine amino acid

Page 3: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

amino acids amino acid hypertonic solutionkanamycin aminoglycoside antibacterialnetilmicin aminoglycoside antibacterialamikacin aminoglycoside antibacterialgentamicin aminoglycoside antibacterialneomycin aminoglycoside antibacterialstreptomycin aminoglycoside antibacterialtobramycin aminoglycoside antibacterialbupropion aminoketonebalsalazide aminosalicylatemesalamine aminosalicylateolsalazine aminosalicylatesulfasalazine aminosalicylatechloramphenicol amphenicol class antibacterialmethamphetamine amphetamine anorecticpramlintide amylin analogdanazol androgenfluoxymesterone androgenmethyltestosterone androgennandrolone androgentestosterone androgenbicalutamide androgen receptor inhibitorenzalutamide androgen receptor inhibitorflutamide androgen receptor inhibitornilutamide androgen receptor inhibitorbenazeprilat angiotensin converting enzyme inhibitorenalaprilat anhydrous angiotensin converting enzyme inhibitorlisinopril anhydrous angiotensin converting enzyme inhibitorperindoprilat angiotensin converting enzyme inhibitorquinaprilat angiotensin converting enzyme inhibitorramiprilat angiotensin converting enzyme inhibitorcaptopril angiotensin converting enzyme inhibitorfosinopril angiotensin converting enzyme inhibitorfosinoprilat angiotensin converting enzyme inhibitorlisinopril angiotensin converting enzyme inhibitormoexipril angiotensin converting enzyme inhibitormoexiprilat angiotensin converting enzyme inhibitortrandolapril angiotensin converting enzyme inhibitortrandolaprilat angiotensin converting enzyme inhibitorazilsartan angiotensin II receptor blockercandesartan angiotensin II receptor blockercandesartan angiotensin II receptor blockereprosartan angiotensin II receptor blockereprosartan angiotensin II receptor blockerirbesartan angiotensin II receptor blockerirbesartan angiotensin II receptor blockerlosartan angiotensin II receptor blocker

Page 4: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

losartan angiotensin II receptor blockerolmesartan angiotensin II receptor blockerolmesartan angiotensin II receptor blockertelmisartan angiotensin II receptor blockertelmisartan angiotensin II receptor blockervalsartan angiotensin II receptor blockervalsartan angiotensin II receptor blockeralbendazole anthelminticoxamniquine anthelminticdiethylcarbamazine anthelminticmebendazole anthelminticpraziquantel anthelminticthiabendazole anthelminticdaunorubicin anthracycline topoisomerase inhibitordoxorubicin anthracycline topoisomerase inhibitorepirubicin anthracycline topoisomerase inhibitoridarubicin anthracycline topoisomerase inhibitorranolazine antianginalamiodarone antiarrhythmiclidocaine antiarrhythmicquinidine antiarrhythmicquinidine antiarrhythmicsotalol antiarrhythmicdisopyramide antiarrhythmicdofetilide antiarrhythmicdronedarone antiarrhythmicflecainide antiarrhythmicibutilide antiarrhythmicmexiletine antiarrhythmicmoricizine antiarrhythmicprocainamide antiarrhythmicpropafenone antiarrhythmicaclidinium anticholinergicatropine anticholinergicbenztropine anticholinergicclidinium anticholinergicdicyclomine anticholinergicglycopyrronium anticholinergicipratropium anticholinergicmepenzolate anticholinergicmethscopolamine anticholinergicpropantheline anticholinergicscopolamine anticholinergictiotropium anticholinergicumeclidinium anticholinergicbiperiden anticholinergicglycopyrrolate anticholinergic

Page 5: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

procyclidine anticholinergictropicamide anticholinergicargatroban anhydrous anticoagulantanhydrous citric acid anti-coagulantbivalirudin anti-coagulantdesirudin anti-coagulantdalteparin anti-coagulantheparin anti-coagulantlepirudin anti-coagulantprotein c anti-coagulantedetic acid anti-coagulantcrofelemer antidiarrhealdifenoxin antidiarrhealdiphenoxylate antidiarrhealacetylcysteine antidotethiosulfuric acid antidoteacetylcysteine antidote for acetaminophen overdosediphenidol antiemeticmeclizine antiemetictrimethobenzamide antiemeticgabapentin antiepileptic drug (AED)gabapentin antiepileptic drug (AED)phenytoin antiepileptic drug (AED)zonisamide antiepileptic drug (AED)ethosuximide antiepileptic drug (AED)ethosuximide antiepileptic drug (AED)ethotoin antiepileptic drug (AED)ethotoin antiepileptic drug (AED)felbamate antiepileptic drug (AED)felbamate antiepileptic drug (AED)lacosamide antiepileptic drug (AED)lacosamide antiepileptic drug (AED)lamotrigine antiepileptic drug (AED)lamotrigine antiepileptic drug (AED)mephenytoin antiepileptic drug (AED)mephenytoin antiepileptic drug (AED)methsuximide antiepileptic drug (AED)methsuximide antiepileptic drug (AED)oxcarbazepine antiepileptic drug (AED)oxcarbazepine antiepileptic drug (AED)primidone antiepileptic drug (AED)primidone antiepileptic drug (AED)tiagabine antiepileptic drug (AED)tiagabine antiepileptic drug (AED)trimethadione antiepileptic drug (AED)trimethadione antiepileptic drug (AED)valproic acid antiepileptic drug (AED)

Page 6: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

valproic acid antiepileptic drug (AED)vigabatrin antiepileptic drug (AED)vigabatrin antiepileptic drug (AED)aprotinin antifibrinolyticaminocaproic acid antifibrinolytictranexamic acid antifibrinolyticbenztropine antihistaminedoxylamine antihistaminehydroxyzine antihistamineglucagon antihypoglycemic agentomalizumab anti-IgEanti-inhibitor coagulant complex

anti-inhibitory coagulant complex

miltefosine antileishmanial drugartemether antimalarialhydroxychloroquine antimalarialquinine antimalarialatovaquone antimalarialchloroquine antimalarialhalofantrine antimalariallumefantrine antimalarialmefloquine antimalarialprimaquine antimalarialproguanil antimalarialthioguanine antimetabolitethioguanine anhydrous antimetabolitefloxuridine antimetabolitehydroxyurea antimetabolitemycophenolic acid antimetabolite immunosuppressantclofazimine antimycobacterialglucosulfone free acid antimycobacterialcapreomycin antimycobacterialethambutol antimycobacterialethionamide antimycobacterialisoniazid antimycobacterialpyrazinamide antimycobacterialstreptomycin antimycobacterialivermectin antiparasiticivermectin antiparasiticaspirin anti-platelet agenteflornithine antiprotozoalnitazoxanide antiprotozoalatovaquone antiprotozoalparomomycin antiprotozoalpentamidine antiprotozoalhydroxychloroquine antirheumaticleflunomide antirheumatic

Page 7: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

penicillamine antirheumaticeteplirsen antisense oligonucleotidemipomersen antisense oligonucleotidenusinersen antisense oligonucleotidepovidone-iodine antiseptichexachlorophene antisepticagkistrodon piscivorus immune fab antivenin (ovine)

antivenin

black widow spider (latrodectus mactans) immune globulin antivenin (equine)

antivenin

centruroides fab2 antivenin (equine)

antivenin

crotalus adamanteus immune fab antivenin (ovine)

antivenin

crotalus atrox immune fab antivenin (ovine)

antivenin

crotalus scutulatus immune fab antivenin (ovine)

antivenin

mipomersen apolipoprotein B-100 synthesis inhibitoranastrozole aromatase inhibitorexemestane aromatase inhibitorletrozole aromatase inhibitortestolactone aromatase inhibitorlevodopa aromatic amino acidcarbidopa aromatic amino acid decarboxylation inhibitorhydralazine arteriolar vasodilatorminoxidil arteriolar vasodilatorasparaginase asparagine-specific enzymepegaspargase asparagine-specific enzymeyellow fever virus strain 17d-204 live antigen

attenuated yellow fever virus vaccine

brexpiprazole atypical antipsychoticcariprazine atypical antipsychoticlurasidone atypical antipsychoticpaliperidone atypical antipsychoticpimavanserin atypical antipsychoticziprasidone atypical antipsychoticaripiprazole atypical antipsychoticasenapine atypical antipsychoticclozapine atypical antipsychoticiloperidone atypical antipsychoticolanzapine atypical antipsychoticquetiapine atypical antipsychoticrisperidone atypical antipsychoticsipuleucel-t autologous cellular immunotherapy

Page 8: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

autologous cultured chondrocytes

autologous cultured cell

azficel-t autologous cultured cellmecamylamine autonomic ganglionic blockermecamylamine autonomic ganglionic blockermecamylamine autonomic ganglionic blockerefinaconazole azole antifungalfluconazole azole antifungalisavuconazole azole antifungalitraconazole azole antifungalketoconazole azole antifungalluliconazole azole antifungalvoriconazole azole antifungalbutoconazole azole antifungalclotrimazole azole antifungaleconazole azole antifungalmiconazole azole antifungaloxiconazole azole antifungalposaconazole azole antifungalsertaconazole azole antifungalsulconazole azole antifungalterconazole azole antifungaltioconazole azole antifungalbutalbital barbituratemethohexital barbituratevenetoclax BCL-2 inhibitorclorazepic acid benzodiazepinealprazolam benzodiazepinechlordiazepoxide benzodiazepineclobazam benzodiazepineclonazepam benzodiazepinediazepam benzodiazepineestazolam benzodiazepineflurazepam benzodiazepinelorazepam benzodiazepinemidazolam benzodiazepineoxazepam benzodiazepinequazepam benzodiazepinetemazepam benzodiazepinetriazolam benzodiazepineflumazenil benzodiazepine antagonistriluzole benzothiazolebutenafine benzylamine antifungalephedrine beta adrenergic agonistepinephrine beta adrenergic agonistisoproterenol beta adrenergic agonistdobutamine beta adrenergic agonist

Page 9: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

metoprolol beta adrenergic blockernebivolol beta adrenergic blockertimolol anhydrous beta adrenergic blockeracebutolol beta adrenergic blockeratenolol beta adrenergic blockerbisoprolol beta adrenergic blockercarteolol beta adrenergic blockercarvedilol beta adrenergic blockeresmolol beta adrenergic blockerlabetalol beta adrenergic blockerlevobunolol beta adrenergic blockermetipranolol beta adrenergic blockernadolol beta adrenergic blockerpenbutolol beta adrenergic blockerpindolol beta adrenergic blockerpropranolol beta adrenergic blockertimolol beta adrenergic blockeravibactam beta lactamase inhibitorvaborbactam beta lactamase inhibitorclavulanic acid beta lactamase inhibitorsulbactam beta lactamase inhibitortazobactam beta lactamase inhibitorlevalbuterol beta-2 adrenergic agonistmetaproterenol beta-2 adrenergic agonistolodaterol beta-2 adrenergic agonistvilanterol beta-2 adrenergic agonistalbuterol beta-2 adrenergic agonistarformoterol beta-2 adrenergic agonistformoterol beta-2 adrenergic agonistpirbuterol beta-2 adrenergic agonistsalmeterol beta-2 adrenergic agonistindacaterol beta2-adrenergic agonistmirabegron beta-3 adrenergic agonistbetaxolol beta-adrenergic receptor inhibitormetformin biguanidecholic acid bile acidursodiol bile acidcholestyramine bile acid sequestrantcolesevelam bile acid sequestrantcolestipol bile acid sequestrantbismuth cation bismuthbismuth subsalicylate bismuthblinatumomab bispecific CD19-directed CD3 T-cell engagerzoledronic acid anhydrous bisphosphonatealendronic acid bisphosphonateetidronic acid bisphosphonateibandronic acid bisphosphonate

Page 10: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

pamidronic acid bisphosphonaterisedronic acid bisphosphonatetiludronic acid bisphosphonatezoledronic acid bisphosphonatecalcium cation blood coagulation factorprothrombin blood coagulation factorthrombin blood coagulation factorthrombin alfa blood coagulation factorpentoxifylline blood viscosity reducerbelimumab B-Lymphocyte stimulator (BLyS)-specific inhibitorbelimumab B-Lymphocyte stimulator (BLyS)-specific inhibitorpegademase bovine bovine intestinal adenosine deaminaseicatibant bradykinin B2 receptor antagonistcyclosporine calcineurin inhibitor immunosuppressanttacrolimus calcineurin inhibitor immunosuppressanttacrolimus anhydrous calcineurin inhibitor immunosuppressantpimecrolimus calcineurin inhibitor immunosuppressantcalcitonin salmon calcitonincalcium calciumcellulose sodium phosphate calcium bindergallium nitrate anhydrous calcium resorption inhibitorgallium nitrate calcium resorption inhibitoretelcalcetide calcium-sensing receptor agonistcinacalcet calcium-sensing receptor agonistcinacalcet calcium-sensing receptor agonistdronabinol cannabinoidnabilone cannabinoidcarglumic acid Carbamoyl Phosphate Synthetase 1 (CPS 1) activatoracetazolamide carbonic anhydrase inhibitoracetazolamide carbonic anhydrase inhibitorbrinzolamide carbonic anhydrase inhibitordichlorphenamide carbonic anhydrase inhibitordorzolamide carbonic anhydrase inhibitorglucarpidase carboxypeptidasedigoxin cardiac glycosidelevocarnitine carnitine analogentacapone catechol o-methyl transferase (COMT) inhibitortolcapone catechol o-methyl transferase (COMT) inhibitorepinephrine catecholaminedopamine catecholaminenorepinephrine catecholaminemetyrosine catecholamine synthesis inhibitordeserpidine catecholamine-depleting sympatholyticreserpine catecholamine-depleting sympatholyticmaraviroc CCR5 co-receptor antagonistefalizumab CD11a-directed humanized IgG1 antibodyobinutuzumab CD20-directed cytolytic antibody

Page 11: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

ocrelizumab CD20-directed cytolytic antibodyofatumumab CD20-directed cytolytic antibodyrituximab CD20-directed cytolytic antibodyibritumomab tiuxetan CD20-directed radiotherapeutic antibodytositumomab CD20-directed radiotherapeutic antibodytositumomab i-131 CD20-directed radiotherapeutic antibodyinotuzumab ozogamicin CD22-directed antibody-drug conjugate (ADC)denileukin diftitox CD25-directed cytotoxinalefacept CD2-directed LFA-3/Fc fusion proteinmuromonab-cd3 CD3 blocker immunosuppressant (antibody)brentuximab vedotin CD30-directed antibody-drug conjugategemtuzumab ozogamicin CD33-directed antibody-drug conjugategemtuzumab ozogamicin CD33-directed antibody-drug conjugatedaratumumab CD38-directed cytolytic antibodyalemtuzumab CD52-directed cytolytic antibodymethyldopa anhydrous central alpha-2 adrenergic agonistclonidine central alpha-2 adrenergic agonistdexmedetomidine central alpha-2 adrenergic agonistguanabenz central alpha-2 adrenergic agonistguanfacine central alpha-2 adrenergic agonistmethyldopa central alpha-2 adrenergic agonisttizanidine central alpha-2 adrenergic agonist4-hydroxybutanoic acid central nervous system depressantsodium oxybate central nervous system depressantamphetamine central nervous system stimulantmethamphetamine central nervous system stimulantcaffeine central nervous system stimulantdexmethylphenidate central nervous system stimulantdextroamphetamine central nervous system stimulantlisdexamfetamine central nervous system stimulantmethylphenidate central nervous system stimulantcefaclor anhydrous cephalosporin antibacterialcefadroxil anhydrous cephalosporin antibacterialcefixime anhydrous cephalosporin antibacterialcefotetan cephalosporin antibacterialceftaroline cephalosporin antibacterialceftazidime anhydrous cephalosporin antibacterialceftolozane cephalosporin antibacterialcephalexin anhydrous cephalosporin antibacterialcephradine cephalosporin antibacterialcephradine anhydrous cephalosporin antibacterialloracarbef anhydrous cephalosporin antibacterialcefaclor cephalosporin antibacterialcefadroxil cephalosporin antibacterialcefazolin cephalosporin antibacterialcefdinir cephalosporin antibacterialcefditoren cephalosporin antibacterial

Page 12: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

cefepime cephalosporin antibacterialcefixime cephalosporin antibacterialcefoperazone cephalosporin antibacterialcefotaxime cephalosporin antibacterialcefoxitin cephalosporin antibacterialcefpodoxime cephalosporin antibacterialcefprozil cephalosporin antibacterialceftazidime cephalosporin antibacterialceftibuten cephalosporin antibacterialceftizoxime cephalosporin antibacterialceftriaxone cephalosporin antibacterialcefuroxime cephalosporin antibacterialcephalexin cephalosporin antibacterialloracarbef cephalosporin antibacteriallubiprostone chloride channel activatorsincalide cholecystokinin (CCK) analogacetylcholine cholinergic agonistcarbamoylcholine cholinergic agonistmethacholine cholinergic agonistcarbachol cholinergic agonistcevimeline cholinergic agonistpilocarpine cholinergic agonistambenonium cholinesterase inhibitorechothiophate cholinesterase inhibitoredrophonium cholinesterase inhibitorneostigmine cholinesterase inhibitorpyridostigmine cholinesterase inhibitordonepezil cholinesterase inhibitorgalantamine cholinesterase inhibitormalathion cholinesterase inhibitorrivastigmine cholinesterase inhibitortacrine cholinesterase inhibitorpralidoxime cholinesterase reactivatorletermovir CMV DNA terminase complex inhibitorcollagenase collagen-specific enzymeeculizumab complement inhibitorzinc cation copper absorption inhibitorcopper copper-containing intrauterine device (IUD)beclomethasone corticosteroidbudesonide corticosteroiddeflazacort corticosteroiddexamethasone corticosteroidflunisolide anhydrous corticosteroidhalobetasol corticosteroidprednisone anhydrous corticosteroidtriamcinolone acetonide corticosteroidalclometasone corticosteroid

Page 13: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

amcinonide corticosteroidbetamethasone corticosteroidclobetasol corticosteroidclocortolone corticosteroidcortisone corticosteroiddesonide corticosteroiddesoximetasone corticosteroiddiflorasone corticosteroidflunisolide corticosteroidfluocinolone acetonide corticosteroidfluocinonide corticosteroidfluorometholone corticosteroidflurandrenolide corticosteroidfluticasone corticosteroidhalcinonide corticosteroidhydrocortisone corticosteroidloteprednol corticosteroidmedrysone corticosteroidmethylprednisolone corticosteroidmometasone corticosteroidprednicarbate corticosteroidprednisolone corticosteroidprednisone corticosteroidrimexolone corticosteroidtriamcinolone corticosteroidketorolac cyclooxygenase inhibitorabiraterone CYP17 inhibitorcobicistat CYP3A inhibitorritonavir CYP3A inhibitorquinidine CYP450 2D6 inhibitorivacaftor cystic fibrosis transmembrane conductance regulator (CFTR) potentiatorcysteamine cystine depleting agentdeoxycholic acid cytolytic drug

2-mercaptoethanesulfonic acid cytoprotective agent

amifostine anhydrous cytoprotective agentamifostine cytoprotective agentbleomycin cytoprotective agentdexrazoxane cytoprotective agentmesna cytoprotective agenteflornithine decarboxylase inhibitorferric ferrocyanide decorporation agenthydroxypropyl cellulose demulcentmonobenzone depigmenting agentsuccinylcholine depolarizing neuromuscular blockertrypan blue diagnostic dyetrypan blue free acid diagnostic dye

Page 14: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

fluorescein diagnostic dyeindocyanine green diagnostic dyebedaquiline diarylquinoline antimycobacterialezetimibe dietary cholesterol absorption inhibitortrimethoprim dihydrofolate reductase inhibitor antibacterialpyrimethamine dihydrofolate reductase inhibitor antimalarialnicardipine dihydropyridine calcium channel blockeramlodipine dihydropyridine calcium channel blockerclevidipine dihydropyridine calcium channel blockerfelodipine dihydropyridine calcium channel blockerisradipine dihydropyridine calcium channel blockernifedipine dihydropyridine calcium channel blockernimodipine dihydropyridine calcium channel blockernisoldipine dihydropyridine calcium channel blockersaxagliptin anhydrous dipeptidyl peptidase 4 (DPP-4) inhibitorlinagliptin dipeptidyl peptidase 4 (DPP-4) inhibitorsitagliptin dipeptidyl peptidase 4 (DPP-4) inhibitoralogliptin dipeptidyl peptidase-4 (DPP-4) inhibitorargatroban anhydrous direct thrombin inhibitorbivalirudin direct thrombin inhibitordesirudin direct thrombin inhibitorlepirudin direct thrombin inhibitordroperidol dopamine-2 (D2) antagonistmetoclopramide dopamine-2 (D2) antagonistapomorphine dopaminergic agonistfenoldopam dopaminergic agonistanidulafungin echinocandin antifungalcaspofungin echinocandin antifungalmicafungin echinocandin antifungalhyaluronidase endoglycosidasehyaluronidase (human recombinant)

endoglycosidase

hyaluronidase, ovine endoglycosidasebosentan anhydrous endothelin receptor antagonistmacitentan endothelin receptor antagonistambrisentan endothelin receptor antagonistbosentan endothelin receptor antagonistnecitumumab epidermal growth factor receptor (EGFR) antagonistpanitumumab epidermal growth factor receptor (EGFR) antagonistcetuximab epidermal growth factor receptor (EGFR) antagonistmethylergonovine ergot derivativebromocriptine ergot derivativecabergoline ergot derivativeergoloids ergotamine derivativedihydroergotamine ergotamine derivativeergotamine ergotamine derivativepergolide ergot-derived dopamine receptor agonist

Page 15: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

darbepoetin alfa erythropoiesis-stimulating agent (ESA)erythropoietin erythropoiesis-stimulating agent (ESA)peginesatide erythropoiesis-stimulating agent (ESA)pegzerepoetin alfa erythropoiesis-stimulating agent (ESA)chloroprocaine ester local anesthetictetracaine ester local anestheticethinyl estradiol estrogenestradiol estrogenestrogens, conjugated estrogenmestranol estrogenbazedoxifene estrogen agonist/antagonistclomiphene estrogen agonist/antagonistospemifene estrogen agonist/antagonistraloxifene estrogen agonist/antagonisttamoxifen estrogen agonist/antagonisttoremifene estrogen agonist/antagonistfulvestrant estrogen receptor antagonistdesmopressin factor VIII activatorbetrixaban factor Xa (FXa) inhibitorapixaban factor Xa inhibitoredoxaban factor Xa inhibitorfondaparinux factor Xa inhibitorrivaroxaban factor Xa inhibitorobeticholic acid farnesoid X receptor (FXR) agonistdelafloxacin fluoroquinolone antibacterialleucovorin folate analogmethotrexate folate analog metabolic inhibitorpemetrexed folate analog metabolic inhibitorpralatrexate folate analog metabolic inhibitorbaclofen GABA A agonistzaleplon GABA A agonistgadolinium cation (3+) gadolinium-based contrast agentgadobutrol gadolinium-based contrast agentzolpidem gamma-aminobutyric acid (GABA) A agonistglucagon gastrointestinal motility inhibitordinutuximab GD2-binding monoclonal antibodydesflurane general anestheticenflurane general anestheticetomidate general anestheticisoflurane general anestheticketamine general anestheticpropofol general anestheticsevoflurane general anestheticnateglinide gliniderepaglinide glinidealbiglutide GLP-1 receptor agonistdulaglutide glucagon-like peptide-1 (GLP-1) receptor agonist

Page 16: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

exenatide glucagon-like peptide-1 (GLP-1) receptor agonistliraglutide glucagon-like peptide-1 (GLP-1) receptor agonistlixisenatide glucagon-like peptide-1 (GLP-1) receptor agonistsemaglutide glucagon-like peptide-1 (GLP-1) receptor agonistteduglutide glucagon-like peptide-2 (GLP-2) analogeliglustat glucosylceramide synthase inhibitormiglustat glucosylceramide synthase inhibitorvancomycin glycopeptide antibacterialpentosan polysulfate glycosaminoglycanchoriogonadotropin alfa gonadotropinfollitropin gonadotropinlutropin alfa gonadotropinmenotropins gonadotropinurofollitropin gonadotropingoserelin gonadotropin releasing hormone (GnRH) agonisthistrelin gonadotropin releasing hormone (GnRH) agonistleuprolide gonadotropin releasing hormone (GnRH) agonistleuprolide gonadotropin releasing hormone (GnRH) agonisttriptorelin gonadotropin releasing hormone (GnRH) agonistnafarelin gonadotropin releasing hormone (GnRH) agonistnafarelin gonadotropin releasing hormone (GnRH) agonistcetrorelix gonadotropin releasing hormone (GnRH) antagonistganirelix gonadotropin releasing hormone (GnRH) antagonistmacimorelin growth hormone (GH) secretagogue receptor agonistpegvisomant growth hormone receptor antagonisttesamorelin growth hormone releasing factor (GRG) analoglinaclotide guanylate cyclase-C agonistplecanatide guanylate cyclase-C agonisturea c-13 H. pylori diagnosticentecavir anhydrous HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI)tenofovir anhydrous HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI)adefovir HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI)entecavir HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI)lamivudine HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI)telbivudine HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI)tenofovir HBV nucleoside analog reverse transcriptase inhibitor (HBV-NRTI)sonidegib hedgehog pathway inhibitorvismodegib hedgehog pathway inhibitorplerixafor hematopoietic stem cell mobilizerprotamine heparin reversal agentglecaprevir hepatitis C virus (HCV) NS3/4A protease inhibitorgrazoprevir anhydrous hepatitis C virus (HCV) NS3/4A protease inhibitorparitaprevir hepatitis C virus (HCV) NS3/4A protease inhibitorsimeprevir hepatitis C virus (HCV) NS3/4A protease inhibitorvoxilaprevir hepatitis C virus (HCV) NS3/4A protease inhibitorboceprevir hepatitis C virus (HCV) NS3/4A protease inhibitortelaprevir hepatitis C virus (HCV) NS3/4A protease inhibitor

Page 17: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

daclatasvir hepatitis C virus (HCV) NS5A inhibitorelbasvir hepatitis C virus (HCV) NS5A inhibitorombitasvir hepatitis C virus (HCV) NS5A inhibitorpibrentasvir hepatitis C virus (HCV) NS5A inhibitorvelpatasvir hepatitis C virus (HCV) NS5A inhibitorledipasvir hepatitis C virus (HCV) NS5A inhibitorsofosbuvir hepatitis C virus (HCV) nucleotide analog NS5B polymerase inhibitordasabuvir hepatitis C virus non-nucleoside NS5B palm polymerase inhibitorpertuzumab HER2/neu receptor antagonistpertuzumab HER2/neu receptor antagonisttrastuzumab HER2/neu receptor antagonisttrastuzumab HER2/neu receptor antagonistemedastine histamine-1 (H1) inhibitoremedastine histamine-1 (H1) inhibitorepinastine histamine-1 (H1) inhibitorepinastine histamine-1 (H1) inhibitorketotifen histamine-1 (H1) inhibitorketotifen histamine-1 (H1) inhibitorolopatadine histamine-1 (H1) inhibitorolopatadine histamine-1 (H1) inhibitoralcaftadine histamine-1 (H1) receptor antagonistcarbinoxamine histamine-1 (H1) receptor antagonistchlorpheniramine histamine-1 (H1) receptor antagonistchlorpheniramine histamine-1 (H1) receptor antagonistfexofenadine histamine-1 (H1) receptor antagonistfexofenadine histamine-1 (H1) receptor antagonistacrivastine histamine-1 (H1) receptor antagonistacrivastine histamine-1 (H1) receptor antagonistbepotastine histamine-1 (H1) receptor antagonistcetirizine histamine-1 (H1) receptor antagonistcetirizine histamine-1 (H1) receptor antagonistdesloratadine histamine-1 (H1) receptor antagonistdesloratadine histamine-1 (H1) receptor antagonistdiphenhydramine histamine-1 (H1) receptor antagonistdiphenhydramine histamine-1 (H1) receptor antagonistlevocetirizine histamine-1 (H1) receptor antagonistlevocetirizine histamine-1 (H1) receptor antagonistazelastine histamine-1 receptor antagonistcimetidine histamine-2 (H2) receptor antagonistcimetidine histamine-2 (H2) receptor antagonistfamotidine histamine-2 (H2) receptor antagonistfamotidine histamine-2 (H2) receptor antagonistnizatidine histamine-2 (H2) receptor antagonistnizatidine histamine-2 (H2) receptor antagonistranitidine histamine-2 (H2) receptor antagonistranitidine histamine-2 (H2) receptor antagonistbelinostat histone deacetylase (HDAC) inhibitor

Page 18: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

panobinostat histone deacetylase (HDAC) inhibitorromidepsin histone deacetylase (HDAC) inhibitorvorinostat histone deacetylase (HDAC) inhibitorenfuvirtide HIV fusion inhibitor (HIV-1 FI)elvitegravir HIV integrase strand transfer inhibitor (HIV-1 INSTI)raltegravir HIV integrase strand transfer inhibitor (HIV-1 INSTI)efavirenz HIV nonnucleoside analog reverse transcriptase inhibitor (HIV-1 NNRTI)nevirapine HIV nonnucleoside analog reverse transcriptase inhibitor (HIV-1 NNRTI)delavirdine HIV nonnucleoside analog reverse transcriptase inhibitor (HIV-1 NNRTI)etravirine HIV nonnucleoside analog reverse transcriptase inhibitor (HIV-1 NNRTI)tenofovir anhydrous HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI)tenofovir HIV nucleoside analog reverse transcriptase inhibitor (HIV NRTI)abacavir HIV nucleoside analog reverse transcriptase inhibitors (HIV NRTI)didanosine HIV nucleoside analog reverse transcriptase inhibitors (HIV NRTI)emtricitabine HIV nucleoside analog reverse transcriptase inhibitors (HIV NRTI)lamivudine HIV nucleoside analog reverse transcriptase inhibitors (HIV NRTI)stavudine HIV nucleoside analog reverse transcriptase inhibitors (HIV NRTI)zidovudine HIV nucleoside analog reverse transcriptase inhibitors (HIV NRTI)amprenavir HIV protease inhibitoratazanavir HIV protease inhibitordarunavir HIV protease inhibitorindinavir anhydrous HIV protease inhibitorlopinavir HIV protease inhibitorritonavir HIV protease inhibitorsaquinavir HIV protease inhibitornelfinavir HIV protease inhibitortipranavir HIV protease inhibitorrilpivirine HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI)rilpivirine HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI)simvastatin HMG CoA-reductase inhibitoratorvastatin HMG CoA-reductase inhibitorfluvastatin HMG CoA-reductase inhibitorlovastatin HMG CoA-reductase inhibitorpitavastatin HMG CoA-reductase inhibitorpravastatin HMG CoA-reductase inhibitorrosuvastatin HMG CoA-reductase inhibitor.alpha.1-proteinase inhibitor human

human alpha-1 proteinase inhibitor

antihemophilic factor human human antihemophilic factorantihemophilic factor, human recombinant

human antihemophilic factor

coagulation factor ix human human blood coagulation factorcoagulation factor ix recombinant human

human blood coagulation factor

coagulation factor vii human human blood coagulation factorcoagulation factor viia human human blood coagulation factor

Page 19: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

coagulation factor viia recombinant human

human blood coagulation factor

coagulation factor x human human blood coagulation factor

factor xiii concentrate (human) human blood coagulation factor

fibrinogen human human blood coagulation factorhuman thrombin human blood coagulation factorvon willebrand factor human human blood coagulation factorhuman c1-esterase inhibitor human C1 esterase inhibitoripilimumab human cytotoxic T-lymphocyte antigen 4 (CTLA-4)-blocking antibody

dolutegravirhuman immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI)

human hepatitis b virus immune globulin

human immunoglobulin

human botulinum neurotoxin a/b immune globulin

human immunoglobulin G

human cytomegalovirus immune globulin

human immunoglobulin G

human immunoglobulin g human immunoglobulin Ghuman rho(d) immune globulin human immunoglobulin Ghuman vaccinia virus immune globulin

human immunoglobulin G

becaplermin human platelet-derived growth factorpembrolizumab human programmed death receptor-1 (PD-1)-blocking antibodyalbumin human human serum albuminramucirumab human vascular endothelial growth factor receptor 2 (VEGFR2) antagonistidarucizumab humanized monoclonal antibody fragment (Fab)sebelipase alfa hydrolytic lysosomal cholesteryl ester-specific enzymetaliglucerase alfa hydrolytic lysosomal glucocerebroside-specific enzymecerliponase alfa hydrolytic lysosomal N-terminal tripeptidyl peptidasesebelipase alfa hydrolytic lysosomal triacylglycerol-specific enzymealglucerase hydrolytic lysozomal glucocerebroside-specific enzymeimiglucerase hydrolytic lysozomal glucocerebroside-specific enzymevelaglucerase alfa hydrolytic lysozomal glucocerebroside-specific enzymealglucosidase alfa hydrolytic lysozomal glycogen-specific enzymeelosulfase alfa hydrolytic lysozomal glycosaminoglycan (GAG)-specific enzymegalsulfase hydrolytic lysozomal glycosaminoglycan (GAG)-specific enzymelaronidase hydrolytic lysozomal glycosaminoglycan (GAG)-specific enzymeidursulfase hydrolytic lysozomal glycosaminoglycan (GAG)-specific enzymeagalsidase beta hydrolytic lysozomal neutral glycosphingolipid-specific enzymenitisinone hydroxyphenyl-pyruvate dioxygenase inhibitorivabradine hyperpolarization-activated cyclic nucleotide-gated channel blockerequine botulinum neurotoxin a/b immune globulin

immunoglobulin G

equine thymocyte immune globulin

immunoglobulin G

Page 20: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

lapine t-lymphocyte immune globulin

immunoglobulin G

ovine digoxin immune fab immunoglobulin G

bordetella pertussis filamentous hemagglutinin antigen (formaldehyde inactivated)

inactivated Bordetella pertussis vaccine

bordetella pertussis fimbriae 2/3 antigen

inactivated Bordetella pertussis vaccine

bordetella pertussis pertactin antigen (formaldehyde inactivated)

inactivated Bordetella pertussis vaccine

bordetella pertussis toxoid antigen (formaldehyde, glutaraldehyde inactivated)

inactivated Bordetella pertussis vaccine

bordetella pertussis toxoid antigen (glutaraldehyde inactivated)

inactivated Bordetella pertussis vaccine

clostridium tetani toxoid antigen (formaldehyde inactivated)

inactivated Clostridium tetani vaccine

corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated)

inactivated Corynebacterium diphtheriae vaccine

haemophilus influenzae type b capsular polysaccharide meningococcal outer membrane protein conjugate antigen

inactivated Haemophilus influenzae B vaccine

haemophilus influenzae type b strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen

inactivated Haemophilus influenzae B vaccine

haemophilus influenzae type b strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen

inactivated Haemophilus influenzae B vaccine

hepatitis a virus strain cr 326f antigen (formaldehyde inactivated)

inactivated hepatitis A virus vaccine

hepatitis a virus strain hm175 antigen (formaldehyde inactivated)

inactivated hepatitis A virus vaccine

hepatitis b virus hbsag surface protein antigen

inactivated hepatitis B virus vaccine

hepatitis b virus subtype adw hbsag surface protein antigen

inactivated hepatitis B virus vaccine

Page 21: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

human papillomavirus type 11 l1 capsid protein antigen

inactivated human Papillomavirus vaccine

human papillomavirus type 16 l1 capsid protein antigen

inactivated human Papillomavirus vaccine

human papillomavirus type 18 l1 capsid protein antigen

inactivated human Papillomavirus vaccine

human papillomavirus type 6 l1 capsid protein antigen

inactivated human Papillomavirus vaccine

influenza a virus a/brisbane/59/2007(h1n1) antigen (propiolactone inactivated)

inactivated influenza A virus vaccine

influenza a virus a/brisbane/59/2007(h1n1) hemagglutinin antigen (propiolactone inactivated)

inactivated influenza A virus vaccine

influenza a virus a/california/7/2009 x-181 (h1n1) hemagglutinin antigen (propiolactone inactivated)

inactivated influenza A virus vaccine

influenza a virus a/uruguay/716/2007 (h3n2) antigen (propiolactone inactivated)

inactivated influenza A virus vaccine

influenza a virus a/victoria/210/2009 x-187 (h3n2) antigen (formaldehyde inactivated)

inactivated influenza A virus vaccine

influenza a virus a/vietnam/1203/2004 (h5n1, clade 1) hemagglutinin antigen (formaldehyde inactivated)

inactivated influenza A virus vaccine

influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated)

inactivated influenza B virus vaccine

influenza b virus b/brisbane/60/2008 antigen (propiolactone inactivated)

inactivated influenza B virus vaccine

influenza b virus b/brisbane/60/2008 hemagglutinin antigen (propiolactone inactivated)

inactivated influenza B virus vaccine

japanese encephalitis virus strain nakayama-nih antigen (formaldehyde inactivated)

inactivated Japanese encephalitis virus vaccine

Page 22: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated)

inactivated Japanese encephalitis virus vaccine

neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen

inactivated meningococcal vaccine

neisseria meningitidis group a capsular polysaccharide antigen

inactivated meningococcal vaccine

neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen

inactivated meningococcal vaccine

neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen

inactivated meningococcal vaccine

neisseria meningitidis group c capsular polysaccharide antigen

inactivated meningococcal vaccine

neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen

inactivated meningococcal vaccine

neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen

inactivated meningococcal vaccine

neisseria meningitidis group w-135 capsular polysaccharide antigen

inactivated meningococcal vaccine

neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen

inactivated meningococcal vaccine

neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen

inactivated meningococcal vaccine

neisseria meningitidis group y capsular polysaccharide antigen

inactivated meningococcal vaccine

neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen

inactivated meningococcal vaccine

Page 23: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

streptococcus pneumoniae type 1 capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 1 capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 10a capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 11a capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 12f capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 14 capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 14 capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 15b capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 17f capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 18c capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 18c capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 19a capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 19a capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

Page 24: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

streptococcus pneumoniae type 19f capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 19f capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 2 capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 20 capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 22f capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 23f capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 23f capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 3 capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 3 capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 33f capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 4 capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 4 capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 5 capsular polysaccharide antigen

inactivated pneumococcal vaccine

Page 25: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

streptococcus pneumoniae type 5 capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 6a capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 6b capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 6b capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 7f capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 7f capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 8 capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 9n capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 9v capsular polysaccharide antigen

inactivated pneumococcal vaccine

streptococcus pneumoniae type 9v capsular polysaccharide diphtheria crm197 protein conjugate antigen

inactivated pneumococcal vaccine

poliovirus type 1 antigen (formaldehyde inactivated)

inactivated poliovirus vaccine

poliovirus type 2 antigen (formaldehyde inactivated)

inactivated poliovirus vaccine

poliovirus type 3 antigen (formaldehyde inactivated)

inactivated poliovirus vaccine

Page 26: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

rabies virus strain flury lep antigen (propiolactone inactivated)

inactivated rabies virus vaccine

rabies virus strain kissling antigen (propiolactone inactivated)

inactivated rabies virus vaccine

rabies virus strain pm-1503-3m antigen (propiolactone inactivated)

inactivated rabies virus vaccine

salmonella typhi ty2 vi polysaccharide antigen

inactivated Salmonella typhi vaccine

salmonella typhi ty21a live antigen

inactivated Salmonella typhi vaccine

yersinia pestis 195/p antigen (formaldehyde inactivated)

inactivated Yersinia pestis vaccine

ingenol mebutate inducer of cell deathamantadine influenza A M2 protein inhibitorrimantadine influenza A M2 protein inhibitoroseltamivir influenza neuraminidase inhibitor (NAI)peramivir influenza neuraminidase inhibitor (NAI)zanamivir influenza neuraminidase inhibitor (NAI)insulin human insulininsulin aspart insulin analoginsulin degludec insulin analoginsulin detemir insulin analoginsulin detemir insulin analoginsulin detemir insulin analoginsulin glargine insulin analoginsulin glargine insulin analoginsulin glargine insulin analoginsulin glulisine insulin analoginsulin glulisine insulin analoginsulin glulisine insulin analoginsulin lispro insulin analoginsulin lispro insulin analoginsulin lispro insulin analogvedolizumab integrin receptor antagonistnatalizumab integrin receptor antagonisthuman leucocyte-derived alpha interferons

interferon alpha

interferon alfa-2a interferon alphainterferon alfa-2b interferon alphainterferon alfacon-1 interferon alphapeginterferon alfa-2b interferon alphapeginterferon alfa-2a interferon alphainterferon gamma-1b interferon gammaanakinra interleukin-1 (IL-1) receptor antagonist

Page 27: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

ustekinumab interleukin-12 antagonistbrodalumab interleukin-17 receptor A (IL-17RA) antagonistixekizumab interleukin-17A antagonistsecukinumab interleukin-17A antagonistbasiliximab interleukin-2 receptor blocking antibodydaclizumab interleukin-2 receptor blocking antibodyguselkumab interleukin-23 antagonisttildrakizumab interleukin-23 antagonistustekinumab interleukin-23 antagonistdupilumab interleukin-4 receptor alpha antagonistmepolizumab interleukin-5 antagonistreslizumab interleukin-5 antagonist

benralizumabinterleukin-5 receptor alpha-directed cytolytic monoclonal antibody (IgG1, kappa)

siltuximab interleukin-6 (IL-6) antagonistsarilumab interleukin-6 (IL-6) receptor antagonisttocilizumab interleukin-6 (IL-6) receptor antagonistorlistat intestinal lipase inhibitordeferasirox iron chelatordeferiprone iron chelatordeferoxamine iron chelatorferric cation iron replacement productferumoxytol non-stoichiometric magnetite

iron replacement product

iron sucrose iron replacement productsodium ferric gluconate complex

iron replacement product

enasidenib isocitrate dehydrogenase-2 inhibitortofacitinib Janus kinase (JAK) inhibitortelithromycin ketolide antibacterialabemaciclib kinase inhibitoracalabrutinib kinase inhibitorafatinib kinase inhibitoralectinib kinase inhibitorbosutinib kinase inhibitorbrigatinib kinase inhibitorcabozantinib kinase inhibitorceritinib kinase inhibitorcobimetinib kinase inhibitorcopanlisib kinase inhibitordabrafenib kinase inhibitordasatinib anhydrous kinase inhibitoreverolimus kinase inhibitoribrutinib kinase inhibitoridelalisib kinase inhibitorlenvatinib kinase inhibitormidostaurin kinase inhibitor

Page 28: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

neratinib kinase inhibitornintedanib kinase inhibitorosimertinib kinase inhibitorpalbociclib kinase inhibitorpazopanib kinase inhibitorponatinib kinase inhibitorregorafenib kinase inhibitorribociclib kinase inhibitorsirolimus kinase inhibitortrametinib kinase inhibitorvemurafenib kinase inhibitoraxitinib kinase inhibitorcrizotinib kinase inhibitordasatinib kinase inhibitorerlotinib kinase inhibitorgefitinib kinase inhibitorimatinib kinase inhibitorlapatinib kinase inhibitornilotinib kinase inhibitorruxolitinib kinase inhibitorsorafenib kinase inhibitorsunitinib kinase inhibitortemsirolimus kinase inhibitorvandetanib kinase inhibitoredetic acid lead chelatoredetic acid lead chelatorpentetic acid lead chelatorsuccimer lead chelatormetreleptin leptin analogfilgrastim leukocyte growth factorpegfilgrastim leukocyte growth factorsargramostim leukocyte growth factorzafirlukast leukotriene receptor antagonist (LTRA)montelukast leukotriene receptor antagonist (LTRA)clindamycin lincosamide antibacterialolive oil lipid emulsionsoybean oil lipid emulsionamphotericin b lipid-based polyene antifungaldalbavancin lipoglycopeptide antibacterialoritavancin lipoglycopeptide antibacterialtelavancin lipoglycopeptide antibacterialdaptomycin lipopeptide antibacterialbacillus anthracis strain v770-np1-r antigens

live attenuated Bacillus anthracis vaccine

bacillus calmette-guerin substrain tice live antigen

live attenuated Bacillus Calmette-Guerin immunotherapy

Page 29: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

bacillus calmette-guerin substrain tice live antigen

live attenuated Bacillus Calmette-Guerin immunotherapy

bacillus calmette-guerin substrain tice live antigen

live attenuated Bacillus Calmette-Guerin vaccine

bacillus calmette-guerin substrain tice live antigen

live attenuated Bacillus Calmette-Guerin vaccine

varicella-zoster virus strain oka/merck live antigen

live attenuated herpes zoster virus vaccine

influenza a virus a/california/7/2009 (h1n1) live(attenuated) antigen

live attenuated influenza A virus vaccine

influenza a virus a/perth/16/2009 (h3n2) live(attenuated) antigen

live attenuated influenza A virus vaccine

measles virus strain enders' attenuated edmonston live antigen

live attenuated measles virus vaccine

mumps virus strain b level jeryl lynn live antigen

live attenuated mumps virus vaccine

human rotavirus a type g1p(8) strain rix4414 live antigen

live attenuated Rotavirus vaccine

rubella virus strain wistar ra 27/3 live antigen

live attenuated rubella virus vaccine

varicella-zoster virus strain oka/merck live antigen

live attenuated Varicella zoster virus vaccine

human adenovirus e serotype 4 strain cl-68578

live human adenovirus type 4 vaccine

human adenovirus b serotype 7 strain 55142

live human adenovirus type 7 vaccine

human rotavirus a type g1p7(5) strain wi79 live antigen

live Rotavirus vaccine

human rotavirus a type g1p7(5) strain wi79 live antigen

live Rotavirus vaccine

human rotavirus a type g2p7(5) strain sc2 live antigen

live Rotavirus vaccine

human rotavirus a type g2p7(5) strain sc2 live antigen

live Rotavirus vaccine

human rotavirus a type g3p7(5) strain wi78 live antigen

live Rotavirus vaccine

human rotavirus a type g3p7(5) strain wi78 live antigen

live Rotavirus vaccine

human rotavirus a type g4p7(5) strain brb live antigen

live Rotavirus vaccine

Page 30: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

human rotavirus a type g4p7(5) strain brb live antigen

live Rotavirus vaccine

human rotavirus a type g6p1a(8) strain wi79 live antigen

live Rotavirus vaccine

human rotavirus a type g6p1a(8) strain wi79 live antigen

live Rotavirus vaccine

vaccinia virus strain new york city board of health live antigen

live vaccinia virus vaccine

vaccinia virus strain new york city board of health live antigen

live vaccinia virus vaccine

proparacaine local anestheticbumetanide loop diureticethacrynic acid loop diureticfurosemide loop diuretictorsemide loop diureticdalteparin low molecular weight heparin (LMWH)enoxaparin low molecular weight heparin (LMWH)tinzaparin low molecular weight heparin (LMWH)levothyroxine L-thyroxine (T4)liotrix L-thyroxine (T4)liotrix L-triiodothyronine (T3)liothyronine L-triiodothyronine (T3)lifitegrast lymphocyte function-associated antigen-1 (LFA-1) antagonistaldesleukin lymphocyte growth factorerythromycin macrolidefidaxomicin macrolide antibacterialazithromycin anhydrous macrolide antimicrobialclarithromycin macrolide antimicrobialazithromycin macrolide antimicrobialerythromycin macrolide antimicrobialcromolyn mast cell stabilizerlodoxamide mast cell stabilizernedocromil mast cell stabilizerpemirolast mast cell stabilizeroprelvekin megakaryocyte growth factorhydroquinone melanin synthesis inhibitortasimelteon melatonin receptor agonistramelteon melatonin receptor agonistpotassium citrate metabolic alkalinizerpotassium citrate anhydrous metabolic alkalinizerdimercaprol metal chelatortrientine metal chelatormafenide methylated sulfonamide antibacterial

Page 31: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

betaine methylating agenttheophylline anhydrous methylxanthinecaffeine methylxanthinetheophylline methylxanthinelomitapide microsomal triglyceride transfer protein inhibitordocetaxel anhydrous microtubule inhibitorcabazitaxel microtubule inhibitordocetaxel microtubule inhibitoreribulin microtubule inhibitorixabepilone microtubule inhibitorpaclitaxel microtubule inhibitorisocarboxazid monoamine oxidase inhibitor (MAOI)phenelzine monoamine oxidase inhibitor (MAOI)rasagiline monoamine oxidase inhibitor (MAOI)selegiline monoamine oxidase inhibitor (MAOI)tranylcypromine monoamine oxidase inhibitor (MAOI)safinamide monoamine oxidase type B (MAO-B) inhibitorselegiline monoamine oxidase type B (MAO-B) inhibitoraztreonam monobactam antibacterial

obiltoxaximabmonoclonal antibody directed against the protective antigen of Bacillus anthracis

raxibacumabmonoclonal antibody directed against the protective antigen of Bacillus anthracis

carbamazepine mood stabilizerlithium cation mood stabilizerlamotrigine mood stabilizerlamotrigine mood stabilizervalproic acid mood stabilizervalproic acid mood stabilizereverolimus mTor inhibitor immunosuppressantsirolimus mTor inhibitor immunosuppressantpalifermin mucocutaneous epithelial cell growth factoracetylcysteine mucolytichydroxocobalamin mucolytic antidote for acetaminophen overdosefomepizole mucolytic antidote for acetaminophen overdoseeluxadoline mu-opioid receptor agonistbethanechol muscarinic agonisthomatropine muscarinic agonistatropine muscarinic antagonisttrospium muscarinic antagonistdarifenacin muscarinic antagonistflavoxate muscarinic antagonistoxybutynin muscarinic antagonistsolifenacin muscarinic antagonisttolterodine muscarinic antagonistcarisoprodol muscle relaxantchlorzoxazone muscle relaxant

Page 32: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

cyclobenzaprine muscle relaxantmethocarbamol muscle relaxantorphenadrine muscle relaxantnesiritide natriuretic peptidesacubitrilat neprilysin inhibitornicotine nicotine agonistniacin nicotinic acidvarenicline nicotinic receptor partial agonistvarenicline nicotinic receptor partial agonistisosorbide dinitrate nitrate vasodilatorisosorbide mononitrate nitrate vasodilatornitroglycerin nitrate vasodilatornitrofurantoin nitrofuran antibacterialphenylacetic acid nitrogen binding agentphenylbutyric acid nitrogen binding agentbenzoic acid nitrogen binding agentsecnidazole nitroimidazole antimicrobialmetronidazole nitroimidazole antimicrobialtinidazole nitroimidazole antimicrobialmemantine N-methyl-D-aspartate (NMDA) receptor antagonistperampanel non-competitive AMPA glutamate receptor antagonistatracurium nondepolarizing neuromuscular blockercisatracurium nondepolarizing neuromuscular blockerpancuronium nondepolarizing neuromuscular blockerrocuronium nondepolarizing neuromuscular blockervecuronium nondepolarizing neuromuscular blockerverapamil nondihydropyridine calcium channel blockerdiltiazem nondihydropyridine calcium channel blockerpramipexole nonergot dopamine agonistropinirole nonergot dopamine agonistbenzonatate non-narcotic antitussiveaspirin nonsteroidal anti-inflammatory drugketorolac nonsteroidal anti-inflammatory drugbromfenac nonsteroidal anti-inflammatory drugcelecoxib nonsteroidal anti-inflammatory drugdiclofenac nonsteroidal anti-inflammatory drugdiflunisal nonsteroidal anti-inflammatory drugetodolac nonsteroidal anti-inflammatory drugfenoprofen nonsteroidal anti-inflammatory drugflurbiprofen nonsteroidal anti-inflammatory drugibuprofen nonsteroidal anti-inflammatory drugindomethacin nonsteroidal anti-inflammatory drugketoprofen nonsteroidal anti-inflammatory drugmefenamic acid nonsteroidal anti-inflammatory drugmeloxicam nonsteroidal anti-inflammatory drugnabumetone nonsteroidal anti-inflammatory drugnaproxen nonsteroidal anti-inflammatory drug

Page 33: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

nepafenac nonsteroidal anti-inflammatory drugoxaprozin nonsteroidal anti-inflammatory drugpiroxicam nonsteroidal anti-inflammatory drugsulindac nonsteroidal anti-inflammatory drugtolmetin nonsteroidal anti-inflammatory drugsibutramine norepinephrine, serotonin, and dopamine reuptake inhibitor anorecticephedrine norepinephrine-releasing agentziconotide N-type calcium channel antagonistflucytosine nucleoside analog antifungalidoxuridine nucleoside analog antiviraltrifluridine nucleoside analog antiviralganciclovir nucleoside analog antiviralribavirin nucleoside analog antiviralcidofovir anhydrous nucleoside analog CMV DNA polymerase inhibitorvalganciclovir nucleoside analog CMV DNA polymerase inhibitorcidofovir nucleoside analog CMV DNA polymerase inhibitorganciclovir nucleoside analog CMV DNA polymerase inhibitor

acyclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

acyclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

acyclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

famciclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

valacyclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

valacyclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

valacyclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

penciclovirnucleoside analog HSV DNA polymerase inhibitor / VZV DNA polymerase inhibitor

mercaptopurine anhydrous nucleoside metabolic inhibitortrifluridine nucleoside metabolic inhibitorazacitidine nucleoside metabolic inhibitorcapecitabine nucleoside metabolic inhibitorclofarabine nucleoside metabolic inhibitorcytarabine nucleoside metabolic inhibitordecitabine nucleoside metabolic inhibitorfludarabine nucleoside metabolic inhibitorfluorouracil nucleoside metabolic inhibitorgemcitabine nucleoside metabolic inhibitormercaptopurine nucleoside metabolic inhibitornelarabine nucleoside metabolic inhibitorpentostatin nucleoside metabolic inhibitoromega-3 fatty acids omega-3 fatty acid

Page 34: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

omega-3-carboxylic acids omega-3 fatty acidcodeine anhydrous opioid agonistmeperidine opioid agonistmorphine opioid agonistpropoxyphene opioid agonistalfentanil opioid agonistcodeine opioid agonistdihydrocodeine opioid agonistfentanyl opioid agonisthydrocodone opioid agonisthydromorphone opioid agonistlevorphanol opioid agonistloperamide opioid agonistmethadone opioid agonistoxycodone opioid agonistoxymorphone opioid agonistremifentanil opioid agonistsufentanil opioid agonisttapentadol opioid agonisttramadol opioid agonistbutorphanol opioid agonist/antagonistnalbuphine opioid agonist/antagonistalvimopan anhydrous opioid antagonistmethylnaltrexone opioid antagonistnaldemedine opioid antagonistnaloxegol opioid antagonistalvimopan opioid antagonistnalmefene opioid antagonistnaloxone opioid antagonistnaltrexone opioid antagonistsuvorexant orexin receptor antagonistmannitol osmotic diureticmagnesium cation osmotic laxativepolyethylene glycol 3350 osmotic laxativepotassium cation osmotic laxativesodium cation osmotic laxativesulfate ion osmotic laxativelactulose osmotic laxativetavaborole oxaborole antifungaltedizolid oxazolidinone antibacteriallinezolid oxazolidinone antibacterialmethylene blue cation oxidation-reduction agentoxytocin oxytociccangrelor P2Y12 platelet inhibitorclopidogrel P2Y12 platelet inhibitorticagrelor P2Y12 platelet inhibitorprasugrel P2Y12 platelet inhibitor

Page 35: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

ferumoxides non-stoichiometric magnetite

paramagnetic contrast agent

gadopentetic acid paramagnetic contrast agentgadoxetic acid paramagnetic contrast agentmangafodipir paramagnetic contrast agentmanganese cation (2+) paramagnetic contrast agentgadobenic acid paramagnetic contrast agentgadodiamide paramagnetic contrast agentgadofosveset paramagnetic contrast agentgadoteridol paramagnetic contrast agentgadoversetamide paramagnetic contrast agentparathyroid hormone parathyroid hormoneteriparatide parathyroid hormone analogabaloparatide parathyroid hormone related peptide [PTHrP(1-34)] analogbuprenorphine partial opioid agonistpentazocine partial opioid agonist/antagonistalirocumab PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) inhibitorevolocumab PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) inhibitorbenzyl alcohol pediculicideivermectin pediculicidespinosad pediculicideimipenem anhydrous penem antibacterialmeropenem anhydrous penem antibacterialdoripenem penem antibacterialertapenem penem antibacterialimipenem penem antibacterialmeropenem penem antibacterialamoxicillin anhydrous penicillin class antibacterialamoxicillin anhydrous penicillin class antibacterialpenicillin g penicillin class antibacterialpenicillin v penicillin class antibacterialpiperacillin anhydrous penicillin class antibacterialamoxicillin penicillin class antibacterialamoxicillin penicillin class antibacterialampicillin penicillin class antibacterialcarbenicillin penicillin class antibacterialdicloxacillin penicillin class antibacterialnafcillin penicillin class antibacterialoxacillin penicillin class antibacterialpiperacillin penicillin class antibacterialticarcillin penicillin class antibacterialfenofibric acid peroxisome proliferator-activated receptor (PPAR) alpha agonistfenofibrate peroxisome proliferator-activated receptor (PPAR) alpha agonistfenofibrate peroxisome proliferator-activated receptor (PPAR) alpha agonistgemfibrozil peroxisome proliferator-activated receptor (PPAR) alpha agonistgemfibrozil peroxisome proliferator-activated receptor (PPAR) alpha agonistpioglitazone peroxisome proliferator-activated receptor (PPAR) alpha agonist

Page 36: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

pioglitazone peroxisome proliferator-activated receptor (PPAR) alpha agonistpioglitazone peroxisome proliferator-activated receptor (PPAR) gamma agonistpioglitazone peroxisome proliferator-activated receptor (PPAR) gamma agonistrosiglitazone peroxisome proliferator-activated receptor (PPAR) gamma agonistrosiglitazone peroxisome proliferator-activated receptor (PPAR) gamma agonistchlorpromazine phenothiazinefluphenazine phenothiazinemesoridazine phenothiazineperphenazine phenothiazineprochlorperazine phenothiazinepromethazine phenothiazinethioridazine phenothiazinetrifluoperazine phenothiazinesapropterin phenylalanine hydroxylase activatorcalcium phosphate binderferric cation phosphate binderferric oxyhydroxide phosphate binderlanthanum cation (3+) phosphate bindersevelamer phosphate binderapremilast phosphodiesterase 4 inhibitorcrisaborole phosphodiesterase 4 inhibitorroflumilast phosphodiesterase 4 inhibitoravanafil phosphodiesterase 5 (PDE5) inhibitorcilostazol phosphodiesterase-3 inhibitormilrinone phosphodiesterase-3 inhibitortadalafil phosphodiesterase-5 (PDE-5) inhibitorsildenafil phosphodiesterase-5 (PDE-5) inhibitorvardenafil phosphodiesterase-5 (PDE-5) inhibitorporfimer photoactivated radical generatormethoxsalen photoactivated radical generatorverteporfin photoenhancerecallantide plasma kallikrein inhibitordextran 40 plasma volume expanderdextran 70 plasma volume expanderdextran 75 plasma volume expanderhetastarch plasma volume expanderhydroxyethyl starch 130/0.4 plasma volume expanderpentastarch plasma volume expanderdipyridamole platelet aggregation inhibitoreptifibatide platelet aggregation inhibitorticlopidine platelet aggregation inhibitortirofiban platelet aggregation inhibitoranagrelide platelet-reducing agentanagrelide platelet-reducing agentcarboplatin platinum-based drugcisplatin platinum-based drugoxaliplatin platinum-based drug

Page 37: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

retapamulin pleuromutilin antibacterialniraparib poly (ADP-ribose) polymerase (PARP) inhibitorolaparib poly (ADP-ribose) polymerase (PARP) inhibitorrucaparib poly (ADP-ribose) polymerase (PARP) inhibitoramphotericin b polyene antifungalnystatin polyene antifungalnatamycin polyene antimicrobialcolistimethate polymixin class antibacterialpolymyxin b polymixin class antibacterialaminolevulinic acid porphyrin precursormethyl aminolevulinate porphyrin precursorpatiromer potassium bindersodium polystyrene sulfonate potassium binderdalfampridine potassium channel blockerezogabine potassium channel openerpotassium cation potassium saltamiloride potassium-sparing diuretictriamterene potassium-sparing diureticprogesterone progesteroneulipristal progesterone agonist/antagonistethynodiol progestinhydroxyprogesterone progestindesogestrel progestindienogest progestindrospirenone progestinetonogestrel progestinlevonorgestrel progestinmedroxyprogesterone progestinmegestrol progestinnorelgestromin progestinnorethindrone progestinnorgestimate progestinmifepristone progestin antagonistlevonorgestrel progestin-containing intrauterine device (IUD)avelumab programmed death ligand-1 (PD-L1) blocking antibodydurvalumab programmed death ligand-1 (PD-L1) blocking antibodyatezolizumab programmed death receptor-1 (PD-1)-blocking antibodynivolumab programmed death receptor-1 (PD-1)-blocking antibodyselexipag prostacyclin receptor agonistiloprost prostacyclineepoprostenol prostacycline vasodilatortreprostinil prostacycline vasodilatoralprostadil prostaglandin analogalprostadil prostaglandin analogalprostadil prostaglandin analogbimatoprost prostaglandin analogbimatoprost prostaglandin analog

Page 38: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

bimatoprost prostaglandin analogcarboprost prostaglandin analogcarboprost prostaglandin analogcarboprost prostaglandin analogdinoprostone prostaglandin analogdinoprostone prostaglandin analogdinoprostone prostaglandin analoglatanoprost prostaglandin analoglatanoprost prostaglandin analoglatanoprost prostaglandin analoglatanoprost prostaglandin analogtafluprost prostaglandin analogtravoprost prostaglandin analogtravoprost prostaglandin analogtravoprost prostaglandin analogunoprostone prostaglandin analogunoprostone prostaglandin analogunoprostone prostaglandin analogalprostadil prostaglandin E1 agonistalprostadil prostaglandin E1 agonistalprostadil prostaglandin E1 agonistmisoprostol prostaglandin-1 (PGE1) analogvorapaxar protease-activated receptor-1 (PAR-1) antagonistixazomib proteasome inhibitorbortezomib proteasome inhibitorcarfilzomib proteasome inhibitorocriplasmin proteolytic enzymeesomeprazole proton pump inhibitorlansoprazole proton pump inhibitoromeprazole proton pump inhibitordexlansoprazole proton pump inhibitorpantoprazole proton pump inhibitorrabeprazole proton pump inhibitorergocalciferol provitamin D2 compoundtrioxsalen psoralenmethoxsalen psoralenazathioprine purine antimetabolitecladribine purine antimetabolitepermethrin pyrethroidpirfenidone pyridoneuridine pyrimidine analogteriflunomide pyrimidine synthesis inhibitor

foscarnetpyrophosphate analog CMV DNA polymerase inhibitor / HSV DNA polymerase inhibitor

finafloxacin quinolone antimicrobialgatifloxacin anhydrous quinolone antimicrobialozenoxacin quinolone antimicrobial

Page 39: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

besifloxacin quinolone antimicrobialciprofloxacin quinolone antimicrobialgatifloxacin quinolone antimicrobialgemifloxacin quinolone antimicrobiallevofloxacin quinolone antimicrobialmoxifloxacin quinolone antimicrobialnorfloxacin quinolone antimicrobialofloxacin quinolone antimicrobialammonia n-13 radioactive diagnostic agentcholine c-11 radioactive diagnostic agentchromate ion cr-51 radioactive diagnostic agent

chromated cr-51 serum albumin radioactive diagnostic agent

cyanocobalamin co-57 radioactive diagnostic agentdotatate gallium ga-68 radioactive diagnostic agentflorbetaben f-18 radioactive diagnostic agentflorbetapir f-18 radioactive diagnostic agentfluciclovine f-18 radioactive diagnostic agentfludeoxyglucose f-18 radioactive diagnostic agentfluoride ion f-18 radioactive diagnostic agentflutemetamol f-18 radioactive diagnostic agentgallium citrate ga-67 radioactive diagnostic agentindium chloride in-111 radioactive diagnostic agentindium in-111 oxyquinoline radioactive diagnostic agentindium in-111 pentetate disodium

radioactive diagnostic agent

indium in-111 pentetreotide radioactive diagnostic agentiobenguane i-131 radioactive diagnostic agentiobenguane sulfate i-123 radioactive diagnostic agentiodinated i-125 serum albumin radioactive diagnostic agentiodine i-123 radioactive diagnostic agentiodohippurate sodium i-131 radioactive diagnostic agentiodohippuric acid i-131 radioactive diagnostic agentioflupane i-123 radioactive diagnostic agentiothalamate sodium, i-125 radioactive diagnostic agentiothalamic acid i-125 radioactive diagnostic agentrubidium cation rb-82 radioactive diagnostic agentrubidium chloride rb-82 radioactive diagnostic agentsodium chromate cr-51 radioactive diagnostic agentsodium fluoride f-18 radioactive diagnostic agentsodium iodide i-123 radioactive diagnostic agenttechnetium tc-99m albumin radioactive diagnostic agenttechnetium tc-99m albumin aggregated

radioactive diagnostic agent

technetium tc-99m apcitide radioactive diagnostic agenttechnetium tc-99m bicisate radioactive diagnostic agenttechnetium tc-99m depreotide radioactive diagnostic agent

Page 40: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

technetium tc-99m disofenin radioactive diagnostic agenttechnetium tc-99m exametazime

radioactive diagnostic agent

technetium tc-99m gluceptate radioactive diagnostic agent

technetium tc-99m mebrofenin radioactive diagnostic agent

technetium tc-99m medronate radioactive diagnostic agenttechnetium tc-99m mertiatide radioactive diagnostic agenttechnetium tc-99m oxidronate radioactive diagnostic agenttechnetium tc-99m pentetate radioactive diagnostic agenttechnetium tc-99m pyrophosphate

radioactive diagnostic agent

technetium tc-99m red blood cells

radioactive diagnostic agent

technetium tc-99m sestamibi radioactive diagnostic agenttechnetium tc-99m sodium pertechnetate

radioactive diagnostic agent

technetium tc-99m succimer radioactive diagnostic agenttechnetium tc-99m sulfur colloid

radioactive diagnostic agent

technetium tc-99m teboroxime radioactive diagnostic agent

technetium tc-99m tetrofosmin radioactive diagnostic agent

technetium tc-99m tilmanocept radioactive diagnostic agent

thallous cation tl-201 radioactive diagnostic agentthallous chloride tl-201 radioactive diagnostic agentxenon xe-127 radioactive diagnostic agentxenon xe-133 radioactive diagnostic agentchromic phosphate p-32 radioactive therapeutic agentiodide ion i-131 radioactive therapeutic agentphosphate ion p-32 radioactive therapeutic agentsamarium sm-153 lexidronam pentasodium

radioactive therapeutic agent

sodium iodide i-131 radioactive therapeutic agentsodium phosphate p-32 radioactive therapeutic agentstrontium cation sr-89 radioactive therapeutic agentstrontium chloride sr-89 radioactive therapeutic agentbarium sulfate radiographic contrast agentethiodized oil radiographic contrast agentmetrizoic acid radiographic contrast agentcarbon dioxide radiographic contrast agentdiatrizoic acid radiographic contrast agentiodipamide radiographic contrast agentiodixanol radiographic contrast agentiohexol radiographic contrast agent

Page 41: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

iopamidol radiographic contrast agentiopromide radiographic contrast agentiothalamic acid radiographic contrast agentioversol radiographic contrast agentioxaglic acid radiographic contrast agentioxilan radiographic contrast agentdenosumab RANK ligand (RANKL) inhibitordrotrecogin alfa (activated) recombinant activated protein Cantithrombin alfa recombinant antithrombindornase alfa recombinant human deoxyribonuclease 1 (rhDNase) enzymesomatropin recombinant human growth hormoneinterferon beta-1a recombinant human interferon betainterferon beta-1b recombinant human interferon betavestronidase alfa recombinant human lysosomal beta glucuronidasetiopronin reducing and complexing thiolcilastatin renal dehydropeptidase inhibitoraliskiren renin inhibitordoxapram respiratory stimulantacitretin retinoidadapalene retinoidalitretinoin retinoidbexarotene retinoidisotretinoin retinoidtazarotene retinoidtretinoin retinoidnetarsudil Rho kinase inhibitorrifampin rifamycin antibacterialrifaximin rifamycin antibacterialrifabutin rifamycin antimycobacterialrifapentine rifamycin antimycobacterialmupirocin RNA synthetase inhibitor antibacterialpalivizumab RSV anti-F protein monoclonal (mAb)monoethanolamine sclerosing agentpolidocanol sclerosing agentsecretin secretin class hormoneatomoxetine selective norepeinephrine reuptake inhibitorcitalopram selective serotonin reuptake inhibitor (SSRI)escitalopram selective serotonin reuptake inhibitor (SSRI)fluoxetine selective serotonin reuptake inhibitor (SSRI)fluvoxamine selective serotonin reuptake inhibitor (SSRI)nefazodone selective serotonin reuptake inhibitor (SSRI)paroxetine selective serotonin reuptake inhibitor (SSRI)sertraline selective serotonin reuptake inhibitor (SSRI)trazodone selective serotonin reuptake inhibitor (SSRI)abatacept selective T cell costimulation modulatorabatacept selective T cell costimulation modulatorbelatacept selective T-cell costimulation blocker

Page 42: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

lorcaserin serotonin 2C receptor agonistalmotriptan serotonin 5-HT1B/1D receptor agonist (triptan)almotriptan serotonin 5-HT1B/1D receptor agonist (triptan)eletriptan serotonin 5-HT1B/1D receptor agonist (triptan)eletriptan serotonin 5-HT1B/1D receptor agonist (triptan)frovatriptan serotonin 5-HT1B/1D receptor agonist (triptan)frovatriptan serotonin 5-HT1B/1D receptor agonist (triptan)naratriptan serotonin 5-HT1B/1D receptor agonist (triptan)naratriptan serotonin 5-HT1B/1D receptor agonist (triptan)rizatriptan serotonin 5-HT1B/1D receptor agonist (triptan)rizatriptan serotonin 5-HT1B/1D receptor agonist (triptan)sumatriptan serotonin 5-HT1B/1D receptor agonist (triptan)sumatriptan serotonin 5-HT1B/1D receptor agonist (triptan)zolmitriptan serotonin 5-HT1B/1D receptor agonist (triptan)zolmitriptan serotonin 5-HT1B/1D receptor agonist (triptan)desvenlafaxine serotonin and norepinephrine reuptake inhibitor (SNRI)levomilnacipran serotonin and norepinephrine reuptake inhibitor (SNRI)duloxetine serotonin and norepinephrine reuptake inhibitor (SNRI)milnacipran serotonin and norepinephrine reuptake inhibitor (SNRI)venlafaxine serotonin and norepinephrine reuptake inhibitor (SNRI)alosetron serotonin-3 (5-HT3) receptor antagonistdolasetron serotonin-3 (5-HT3) receptor antagonistgranisetron serotonin-3 (5-HT3) receptor antagonistondansetron serotonin-3 (5-HT3) receptor antagonistpalonosetron serotonin-3 (5-HT3) receptor antagonisttegaserod serotonin-4 (5-HT4) receptor antagonistdextromethorphan sigma-1 agonistdantrolene skeletal muscle relaxantmequinol skin lightening agentcoccidioides immitis spherule skin test antigentuberculin purified protein derivative

skin test antigen

elotuzumab SLAMF7-directed immunostimulatory antibodycanagliflozin anhydrous sodium-glucose co-transporter 2 (SGLT2) inhibitordapagliflozin sodium-glucose co-transporter 2 (SGLT2) inhibitorempagliflozin sodium-glucose co-transporter 2 (SGLT2) inhibitorriociguat soluble guanylate cyclase (sGC) stimulatorpasireotide somatostatin analoglanreotide somatostatin analogoctreotide somatostatin analogfingolimod sphingosine 1-phosphate receptor modulatordeacetylbisacodyl stimulant laxativedalfopristin streptogramin antibacterialquinupristin streptogramin antibacterialaprepitant substance P/neurokinin-1 (NK-1) receptor antagonistnetupitant substance P/neurokinin-1 (NK-1) receptor antagonistrolapitant substance P/neurokinin-1 (NK-1) receptor antagonist

Page 43: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

sacrosidase sucrose specific enzymesulfadoxine sulfonamidesilver sulfadiazine sulfonamide antibacterialsulfadiazine sulfonamide antibacterialsulfacetamide sulfonamide antibacterialsulfamethoxazole sulfonamide antimicrobialsulfisoxazole sulfonamide antimicrobialdapsone sulfonechlorpropamide sulfonylureaglimepiride sulfonylureaglipizide sulfonylureaglyburide sulfonylureatolazamide sulfonylureatolbutamide sulfonylureaberactant surfactantcalfactant surfactantporactant alfa surfactantnusinersen survival motor neuron-2 (SMN2)-directedbenzphetamine sympathomimetic amine anorecticdiethylpropion sympathomimetic amine anorecticphendimetrazine sympathomimetic amine anorecticphentermine sympathomimetic amine anorecticmodafinil sympathomimetic-like agenttigecycline tetracycline class antibacterialoxytetracycline anhydrous tetracycline class antimicrobialdemeclocycline tetracycline class antimicrobialoxytetracycline tetracycline class antimicrobialtetracycline tetracycline class antimicrobialminocycline tetracycline class drugdoxycycline anhydrous tetracycline-class druglenalidomide thalidomide analogpomalidomide thalidomide analogbendroflumethiazide thiazide diureticchlorothiazide thiazide diuretichydrochlorothiazide thiazide diuretichydroflumethiazide thiazide diureticmethyclothiazide thiazide diureticpolythiazide thiazide diureticchlorthalidone thiazide-like diureticindapamide thiazide-like diureticmetolazone thiazide-like diureticpioglitazone thiazolidinedionepioglitazone thiazolidinedionerosiglitazone thiazolidinedionerosiglitazone thiazolidinedioneurokinase thrombolytic agenteltrombopag thrombopoietin receptor agonist

Page 44: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

romiplostim thrombopoietin receptor agonisttipiracil thymidine phosphorylase inhibitormethimazole thyroid hormone synthesis inhibitorpropylthiouracil thyroid hormone synthesis inhibitorthyrotropin alfa thyroid stimulating hormoneasfotase alfa tissue nonspecific alkaline phosphataseetoposide topoisomerase inhibitoririnotecan topoisomerase inhibitormitoxantrone topoisomerase inhibitorteniposide topoisomerase inhibitortopotecan topoisomerase inhibitoramitriptyline tricyclic antidepressant (TCA)amoxapine tricyclic antidepressant (TCA)clomipramine tricyclic antidepressant (TCA)desipramine tricyclic antidepressant (TCA)doxepin tricyclic antidepressant (TCA)imipramine tricyclic antidepressant (TCA)nortriptyline tricyclic antidepressant (TCA)protriptyline tricyclic antidepressant (TCA)trimipramine tricyclic antidepressant (TCA)telotristat tryptophan hydroxylase inhibitortuberculin purified protein derivative

tuberculosis skin test

griseofulvin tubulin inhibiting agentadalimumab tumor necrosis factor (TNF) blockercertolizumab tumor necrosis factor (TNF) blockercertolizumab pegol tumor necrosis factor (TNF) blockeretanercept tumor necrosis factor (TNF) blockergolimumab tumor necrosis factor (TNF) blockerinfliximab tumor necrosis factor (TNF) blockerinfliximab tumor necrosis factor (TNF) blockerinfliximab tumor necrosis factor (TNF) blockerhaloperidol typical antipsychoticmolindone typical antipsychoticpimozide typical antipsychoticthiothixene typical antipsychotichuman albumin microspheres ultrasound contrast agentperflexane ultrasound contrast agentsulfur hexafluoride ultrasound contrast agentperflutren ultrasound contrast agentdextromethorphan uncompetitive NMDA receptor antagonistheparin unfractionated heparinlesinurad URAT1 inhibitoracetohydroxamic acid urease inhibitorpegloticase uric acid specific enzymerasburicase uric acid specific enzymeanhydrous citric acid urinary calculi dissolution agent

Page 45: FDA Established Pharmacologic Class (EPC) Text Phrase PLR ... · FDA Established Pharmacologic Class (EPC) Text Phrase PLR regulations require that the following statement is

anhydrous citric acid urinary calculi dissolution agentmagnesium cation urinary calculi dissolution agentgluconolactone urinary calculi dissolution agentaflibercept vascular endothelial growth factor (VEGF) inhibitorranibizumab vascular endothelial growth factor (VEGF) inhibitorbevacizumab vascular endothelial growth factor-specific angiogenesis inhibitorangiotensin ii vasoconstrictoroxymetazoline vasoconstrictornitroprusside vasodilatornitric oxide vasodilatordesmopressin vasopressin analogconivaptan vasopressin receptor antagonisttolvaptan vasopressin V2-receptor antagonisttetrabenazine vesicular monoamine transporter 2 (VMAT2) inhibitorvalbenazine vesicular monoamine transporter 2 (VMAT2) inhibitorvinblastine vinca alkaloidvincristine vinca alkaloidvinorelbine vinca alkaloidvitamin a vitamin Aaminobenzoic acid vitamin B complex membercyanocobalamin vitamin B12pyridoxine Vitamin B6 analogascorbic acid vitamin Ccholecalciferol vitamin Dcalcipotriene vitamin D analogdoxercalciferol vitamin D2 analogcalcifediol anhydrous vitamin D3 analogcalcitriol vitamin D3 analogparicalcitol vitamin D3 analogphenprocoumon vitamin K antagonistwarfarin vitamin K antagonistphytonadione vitamin K replacementphytonadione warfarin reversal agentallopurinol xanthine oxidase inhibitorfebuxostat xanthine oxidase inhibitor